NCT03938922View on ClinicalTrials.gov

A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 1, 2024

Primary Completion Date

June 15, 2025

Study Completion Date

December 15, 2025

Conditions
Parkinson DiseaseDementia
Interventions
DRUG

Active Investigational Treatment ENT-01

"ENT-01 will be administered in tablet form, once daily.~Other Names:~ENT-01"

Trial Locations (3)

45459

Elias Research - Neurology Diagnostics Research, Dayton

93710

Neuro Pain Medical Center, Fresno

08755

Evolution Research Group - Neuroscience Research Institution, Toms River

Sponsors

Lead Sponsor

Enterin Inc.
All Listed Sponsors
lead

Enterin Inc.

INDUSTRY